Navigation Links
Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
Date:10/7/2010

reader with the following Key benefits:

* In-depth understanding of co-promotion and co-marketing deal trends since 2000

* Analysis of the structure of co-promotion and co-marketing agreements with numerous real life case studies

* Comprehensive access to over 700 actual co-promotion and co-marketing contracts entered into by the world's biopharma companies

* Detailed access to actual co-promotion and co-marketing contracts enter into by the leading fifty bigpharma companies

* Insight into the terms included in a co-promotion and co-marketing agreement, together with real world clause examples

* Understand the key deal terms companies have agreed in previous deals

* Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scopeCo-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics is intended to provide the reader with an in-depth understanding of the co-promotion and co-marketing trends and structure of deals entered into by leading biopharma companies worldwide.

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics includes:

* Trends in co-promotion and co-marketing dealmaking in the biopharma industry since 2000

* Analysis of co-promotion and co-marketing deal structure

* Case studies of real-life co-promotion and co-marketing deals

* Access to over 700 co-promotion and co-marketing contract documents

* The leading co-promotion and co-marketing deals by value since 2000

* Most active co-promotion and co-marketing dealmakers since 2000

* The leading co-promotion and co-marketing partnering resources

In Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics , the available contracts are listed by:

* Company A-Z

* Headline value

* Stage of developm
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Reportlinker Adds Global Vertebral Compression Fracture Devices Industry
2. Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies
3. Reportlinker Adds US Pharmaceutical Market Overview - Healthcare reform, economic pressures and the patent cliff set to impact Pharma
4. Reportlinker Adds Antidiabetics Market Forecast
5. Reportlinker Adds Global Anti-CD20 Monoclonal Antibodies Industry
6. Reportlinker Adds Global Intravenous (IV) Iron Drugs Industry
7. Reportlinker Adds Global Sleeping Pills Industry
8. Reportlinker Adds Global Immunoassay Systems Industry
9. Reportlinker Adds Global Medical Plastics Industry
10. Reportlinker Adds Global Optoelectronics Industry
11. Reportlinker Adds Global Gas Chromatography Systems Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... VANCOUVER , July 30, 2015  OncoGenex Pharmaceuticals, ... will report its second quarter 2015 financial results on ... conference call and live webcast at 4:30 p.m. Eastern ... development programs and a general corporate update. ... Investor Relations page of the OncoGenex website at ...
(Date:7/30/2015)... 30, 2015  Cleveland Clinic President Wael Barsoum ... last month that industry is compelled to adopt declining ... the efficiencies—and develop the transformational innovations -- required to ... were preceded by Doug Kohrs , past President ... who stressed that industry must add "episode of care," ...
(Date:7/30/2015)...  Medimetriks Pharmaceuticals, Inc. announced today that its ... study for Ozenoxacin, a novel bactericidal non-fluorinated quinolone ... U.S. rights to Ozenoxacin 1% cream.  ... with an emphasis on U.S. patients, involved 412 ... older with a clinical diagnosis of bullous or ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
... PRINCETON, N.J., Feb. 2, 2011 Eli Lilly and ... Company (NYSE: BMY ) announced today that ... global Phase III studies evaluating necitumumab, an investigational anti-cancer ... lung cancer (NSCLC). (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO) ...
... BOTHELL, Wash., Feb. 2, 2011 Cardiac Science Corporation ... ) and diagnostic cardiac monitoring devices, has been ... Flow Control facilities globally. Tyco Flow Control is a $3.4B ... facilities throughout the globe. The first phase of the rollout, ...
Cached Medicine Technology:Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 2Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 3Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 4Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 5Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 6Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 7Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 8Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 9Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 10Tyco Division Awards Global AED Contract to Cardiac Science 2Tyco Division Awards Global AED Contract to Cardiac Science 3Tyco Division Awards Global AED Contract to Cardiac Science 4
(Date:7/31/2015)... ... July 31, 2015 , ... Recently, ZKB filed another federal ... Division (Case No. 3:15-cv-00397) involving the Implanon® contraceptive implant . , As ... their Implanon® implants, inability to locate the implants, unsuccessful and invasive attempts at ...
(Date:7/31/2015)... ... 2015 , ... Florida Hospital Tampa has started treating select ... targeted delivery of fluids to selected sites in the peripheral vascular system. Patients ... the device that provides direct, local delivery of chemotherapy to the pancreas. This ...
(Date:7/31/2015)... ... , ... Awarded to only the Top 10 hair transplant practices in the ... latest recipients of the Center of Clinical Excellence for ARTAS Robotic Hair Transplantation ... the science of hair transplant. , Parsa Mohebi Hair Restoration is known worldwide for ...
(Date:7/31/2015)... ... July 31, 2015 , ... Healthpointe , a ... redesigned website at Healthpointe.net. The new website will feature a sleek and streamlined ... serves to provide smoother interactions between patients and the Healthpointe clinics and ensures ...
(Date:7/31/2015)... ... July 31, 2015 , ... The ... Karmanos Center for Natural Birth . The Karmanos Center for Natural Birth ... childbirth experience. With nurses and caregivers that are trained in holistic birth approaches, ...
Breaking Medicine News(10 mins):Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:Healthpointe Announces Newly Redesigned Website 2
... ... been associated with numerous warnings. If YAZ®/Yasmin® side effects have resulted in ... ... -- The widely-used oral contraceptive YAZ® (alternatively named Yasmin® ) has recently been targeted ...
... 11 Emdeon Inc. (the "Company") today announced the pricing of ... common stock at a price of $15.50 per share. Of the ... were offered by selling stockholders. The shares will be listed on ... the extent that the underwriters sell more than 23,700,000 shares of ...
... , , , ... to repay more than $500 million in benefits that were unlawfully ... part of a class action settlement preliminarily approved by U.S. District ... were suspended or denied between 2000 and 2006 will be notified ...
... , LIONVILLE, Pa., Aug. 11 West ... Federici, Chief Financial Officer, and Michael Anderson, Vice President, Treasurer and Head ... Ideas" Summer Conference on Tuesday, August 18, 2009 in White Plains, NY. ... presentation or a webcast, Mr. Federici and Mr. Anderson will present a ...
... , , , ... Web site , , CHICAGO, Aug. 11 ... o to/publicsurvey and become eligible to win a ... Web site, ADA.org. , , ADA.org provides news and information ...
... , , ATLANTA, Aug. 11 Sean Carroll, CEO ... , has been appointed to serve as a board member of the ... AHI M A ). The ... 1962, is a non-profit organization that provides development, research and scholarships for ...
Cached Medicine News:Health News:Ohio Law Firm Warns of Birth Control Pill YAZ/Yasmin Side Effects Lawsuits 2Health News:Ohio Law Firm Warns of Birth Control Pill YAZ/Yasmin Side Effects Lawsuits 3Health News:Ohio Law Firm Warns of Birth Control Pill YAZ/Yasmin Side Effects Lawsuits 4Health News:Emdeon Inc. Prices Initial Public Offering of Class A Common Stock at $15.50 Per Share 2Health News:Emdeon Inc. Prices Initial Public Offering of Class A Common Stock at $15.50 Per Share 3Health News:Emdeon Inc. Prices Initial Public Offering of Class A Common Stock at $15.50 Per Share 4Health News:Government Stops Unlawful Social Security Suspensions; Agrees to Repay More Than Half a Billion in Back Benefits 2Health News:American Dental Association Web Survey Offers Chance at $150 Gift Certificate 2Health News:Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors 2
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
MBS 0.2 ml satellite block unit with height adjusting heated lid, 96 well standard block - holds 96 x 0.2ml tubes or 1 x 96 well plate (includes tube thermistor)...
PxE thermal Cycler. 0.2ml, 96 well block holds 96 tubes or 1 x 96 well plate. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User f...
... (PxE) is a licensed 96 well PCR machine, ... for money thermal cycling. It is built ... in manufacturing and retains a high level of ... products in the range. The combination of ...
Medicine Products: